BMAL1 and neoplasm: On the other hand, and similar to BMAL1 KD, the downregulation of NR1D1 led to a significant reduction of proliferation (~50% reduction, p = 0.0008) and tumour size (~24% reduction, p = 0.0012) (Figure 4E–G).